EKF Diagnostics Holdings plc

Good afternoon and welcome to the EKF Diagnostics Holdings plc investor presentation. Throughout this recorded presentation investors will be in listen only mode. Questions are encouraged and could be submitted at any time via the Q&A tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself, however the company can review all questions submitted today and publish responses where it's appropriate to do so. Before we begin I'd like to submit the following poll. I'd now like to hand you over to Gavin Jones, CEO. Good afternoon sir.

Thank you very much. Good afternoon everyone and thank you for joining us. As already said, I'm Gavin Jones, CEO at EKF and I'm joined today by Helen Jones, our new CFO. We're pleased to walk you through a solid set of interim results for the first half of 2026 and update you on the progress we're making against our five year strategy. For anyone newer to the EKF story, We operate across two complementary divisions point of care where we manufacture diagnostic devices and tests that deliver rapid accurate results right where they're needed at or near the patient this is distributed through our global partner network reaching over 120 countries our life sciences division supplies high quality reagents enzymes and contract manufacturing services Julian Huw Baines, Briefly on us, I joined EKF in 2013 and served as Chief Product Officer before stepping into the CEO role in March 2025. So I do bring a real continuity on product regulatory and commercial execution. Helen joined as CFO in April 2026 and I'll allow Helen to introduce herself.

Thank you, Gavin. So good afternoon, everybody. My name is Helen and as Gavin said I'm the CFO of EKF since end of April 2026. So just in terms of by way of background I started my 20th career at PwC, qualified there as a Chartered Accountant and for the last 10 years I've worked within a number of different aim listed businesses and I'm formerly CFO of aim listed company Intelligent Ultrasound for five years. I'm experienced across all areas of financing including tax transfer pricing Fundraising, M&A, restructuring and I'm excited to bring my skills and knowledge to EKS in leading the finance function and helping Gavin and the team drive forward the five-year strategy.